Association of PCSK9 Serum Levels with Lipid Metabolism Dysregulation, Activity/Damage Scores and Subclinical Atherosclerosis in SLE Patients

被引：0
|
作者：
Sanchez-Perez, Hiurma [1 ]
Carlos Quevedo, Juan [2 ]
Rua-Figueroa, Inigo [3 ]
Tejera-Segura, Beatriz [4 ]
De Vera-Gonzalez, A. M. [5 ]
Gonzalez-Delgado, Alejandra [6 ]
Diaz-Gonzalez, Federico [7 ]
Ferraz-Amaro, Ivan [8 ]
机构：
[1] Hosp Univ Canarias, Div Rheumatol, Rheumatol, San Cristobal la Laguna, Spain
[2] Hosp Doctor Negrin, Rheumatol, Las Palmas Gran Canaria, Spain
[3] Hosp Doctor Negrin, Div Rheumatol, Las Palmas Gran Canaria, Spain
[4] Hosp Insular Gran Canaria, Div Rheumatol, Las Palmas Gran Canaria, Spain
[5] Hosp Univ Canarias, Div Cent Lab, San Cristobal La Laguna, Spain
[6] Hosp Univ Canarias, Div Cent Lab, Tenerife, Spain
[7] Hosp Univ Canarias, Serv Reumatol, Reumatol, San Cristobal la Laguna, Spain
[8] Hosp Univ Canarias, Div Rheumatol, Tenerife, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
744
引用
收藏
页数：2
相关论文
共 50 条
  • [21] NO ASSOCIATION BETWEEN CHANGES IN LIPID PARAMETERS AND TOTAL PCSK9 IN CORONARY ARTERY DISEASE PATIENTS TREATED WITH PCSK9 INHIBITORS
    Ugovsek, S.
    Likozar, A. Rehberger
    Sebestjen, M.
    ATHEROSCLEROSIS, 2023, 379 : S173 - S173
  • [22] ASSOCIATION OF SERUM LIPID PROFILE WITH PEDIATRIC SEPTIC SHOCK OUTCOMES AND PCSK9 GENOTYPE
    Atreya, Mihir R.
    Whitacre, Brynne
    Wong, Hector
    SHOCK, 2020, 53 : 105 - 106
  • [23] Serum PCSK9 levels in infants with deviant birth weight: a biomarker of the lipoprotein metabolism
    Vlahos, Antonios
    Rallis, Dimitrios
    Lianou, Alexandra
    Baltogianni, Maria
    Dermitzaki, Niki
    Maragoudaki, Eleni
    Papastergiou, Eleni
    Tzallas, Christos
    Tsabouri, Sophia
    Makis, Alexandros
    Siomou, Ekaterini
    Milionis, Haralambos
    Giapros, Vasileios
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (01):
  • [24] Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels
    Tao Guo
    Rui-Xing Yin
    Feng Huang
    Li-Mei Yao
    Wei-Xiong Lin
    Shang-Ling Pan
    Scientific Reports, 6
  • [25] Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels
    Guo, Tao
    Yin, Rui-Xing
    Huang, Feng
    Yao, Li-Mei
    Lin, Wei-Xiong
    Pan, Shang-Ling
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Analysis of the Association between PCSK9 Levels and Plasma Lipid Levels in Cameroonians with Type 2 Diabetes
    Camille, B. M.
    Mbacham, Wilfred F.
    Sobngwi, Eugene
    Mbanya, Jean Claude
    DIABETES, 2018, 67
  • [27] Plasma PCSK9 levels and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
    Panahi, Y.
    Ghahrodi, M. S.
    Jamshir, M. S.
    Safarpour, M. A.
    Pirro, M.
    Bianconi, V.
    Farahani, M. M.
    Banach, M.
    Sahebkar, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 472 - 472
  • [28] Association between plasma PCSK9 levels and lipid profile in patients with Parkinson's disease and comparison with healthy subjects
    Jahed, Mohammad Reza
    Habibi, Seyed Amir Hassan
    Vaseghi, Golnaz
    Amiri, Hasan
    Montazeri, Hamed
    Eshraghi, Azedeh
    CURRENT JOURNAL OF NEUROLOGY, 2022, 21 (04): : 236 - 243
  • [29] Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
    Levstek, Tina
    Karun, Tina
    Likozar, Andreja Rehberger
    Sebestjen, Miran
    Podkrajsek, Katarina Trebusak
    GENES, 2023, 14 (03)
  • [30] GREATER LIKELIHOOD OF REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB, IN PATIENTS WITH HIGHER LP(A) LEVELS
    Scherer, Daniel
    Puri, Rishi
    Ballantyne, Christie
    Cho, Leslie
    Brennan, Danielle
    Kassahun, Helina
    Somaratne, Ransi
    Wasserman, Scott
    Nissen, Steven
    Nicholls, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 17 - 17
12345